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A 3 kb cDNA clone has previously been isolated in this laboratory corresponding to the rat heavy neurofilament poly- 
peptide (NF-H). This clone, equivalent to approximately 70% of the total mRNA of the protein has been sequenced and 
shown to contain the carboxy-terminal region of the message. This contains 51 of the Lys-Ser-Pro repeat triplets which 
are reported to be the site of neurofilament phosphorylation. The sequence obtained was subsequently compared to those 
of mouse and human NF-H, showing a homology of approximately 85%. There is, however, one region which is variable 
between the species, this being the highly phosphorylated r gion of the protein containing the Lys-Ser-Pro triplet repeat. 
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1. INTRODUCTION 
Neurof i laments (NF), the neuronal  intermediate 
f i laments,  are composed of  three polypept ides of  
apparent  molecular  mass, determined by SDS- 
PAGE,  approx.  70 kDa (NF-L),  160 kDa (NF-M) 
and 200 kDa (NF-H)  and are involved in the 
maintenance of  neuronal  cal iber [1]. Phosphory la-  
t ion probab ly  plays a major  role in the functioning 
of  the two larger neurof i lament polypeptides (NF- 
M and NF-H) ,  the levels of  phosphory lat ion being 
altered developmental ly  and coincident with a 
change in neurof i lament funct ion [2,3]. Both NF-  
M and NF-H contain a heavily phosphory lated 
carboxy region which may influence the format ion 
of  f i lament- f i lament axonal  cross bridges [4,5]. 
The NF-L  and NF-M genes and cDNAs have 
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been cloned and sequenced [6-11] and also those 
of  the mouse and human NF-H [12,13]. More 
recently, a part ia l  cDNA clone for rat NF-H  has 
been sequenced [14]. We have previously reported 
the isolat ion of  a part ia l  cDNA clone for rat NF-H  
[15] which extends over 200 bases further towards 
the N-terminal  and here we describe the sequence 
of  the clone which corresponds to approx.  7007o f  
the total  message. The clone contains the triplet 
repeat Lys-Ser-Pro sequence which is present in the 
carboxy-terminal  region and is repeated 51 times, 
this being the putat ive phosphory lat ion  region of  
the protein.  The sequence of  the rat tr iplet repeat 
region is then compared to those of  human and 
mouse NF-H.  
2. MATERIALS  AND METHODS 
2.1. Preparation and screening of  a rat brain cDNA library 
The cDNA library was prepared and screened as previously 
described [15] yielding a clone of 3 kb in length. 
2.2. DNA sequencing 
The clone obtained was inserted into the Bluescript expres- 
sion vector. Deletion mutants were generated using the Exo 
Ill/mung bean nuclease system (Stratagene) and these were se- 
quenced by the dideoxy chain termination method [16]. 
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I CAC CAG GAG GAG GTG GGC GAG CTG CTC 
His Gln Glu Glu Val  Gly  GIu Leu Leu 
97 GAC GTG ACG TCG GCG CTG CGG GAG ATC 
Asp Val Thr  Set  Aln Leu Arg GIu !le 
193 GAC CGA CTC TCA GAG GCA GCC AAA GTG 
Asp Arg Leu Set GIu Ala Ala Lys Val  
289 ACA GAG TTG GAG GCA CTG AAA AGC ACC 
Tbr  GIu Leu GIu Ala Leu Lys 9~r Thr  
585 GAT GCA ATT CAG CAG CTG GAC AAT GAG 
Asp Ala I le Gln Gln Lau Asp ASh GIu 
481 GCC CTG GAT CTT GAG ATC GCT GCT TAC 
Ala Leu Asp Leu GIu I le Ala A la  Tyr 
577 "CTC CCA AAA ATT CCC TCC ATG TCC ACT 
Leu Pro Lys l le Pro Set  Met Set  Thr  
672 GAG GAA CAG ACA GAA GAG ATC CAG GTG 
GIU Glu Gin Thr  Glu GIu !le Sln Val  
768 GGA GAA GAA GCA GCA ACT ACG TCT CCC 
Gly GIU GIu Ala Ala ThrThr  Ser Pro 
865 GCT GAG GCC AAG TCC CCA GCT GAG GCC 
Ala GIu Ala Lys Set Pro Ala Glu Ala 
961 GTC AAA. TCT CCA GCT GAG GTC AAA TCT 
Val Lys Set  Pro Ala Glu Val Lys Set 
1057 TCT CCA GGT GAG GCC AAG TCC CCA GCT 
Set  Pro Gly Glu Ala Lym Set Pro Ala 
1153 GCT TCA GTG AAG TCC CCA GGT GAG GCC 
Ala Set  Val  Lys Set Pro Gly GIu Ala 
1249 GCC AAG TCA CCA GCT GAG GTC AAA TCT 
Ala Lys Set  Pro Ala Glu Val Lym Ser 
1345 TCC CCA AGT GAA GCC AAG TCA CCT GCT 
Set  Pro Set  Glu Ala Lys Set Pro Ala 
1441 GCT GGA GCC AAG CCT CCA GCT GAG GCC 
Ala Gly  Ala Lys Pro Pro Ala Glu A1a 
1537 GCC AAG TCA CCT GTT GAG GTA AAA TCT 
Ala Lys Set Pro Val  GIu Val Lys Ser  
1623 GCC AAG TCC CCT GTG A~G GAA GAG ATC 
Ala Ly= Set Pr~ V~! Ly3 Glu Glu Ila 
1729 &AG AAG GCC AAG ACT C£G GAT GTG AAG 
GIU Lys Ala Ly9 Thr  Lau Asp Val Lys 
1825 GTC AAA AGT CCT GCC AAG GAG GAG GCC 
Val Lys Set  Pro Ala Lys GIU GIU Ala 
1521 GTG GAG GAG GTA AAA GCC AAA GAA CCC 
Val Glu Glu Val  Lys Ala Lys GIu Pro 
2017 GAA GCT CCC AAG GAG GCC CAG AAG CCC 
GI~ Ala Pro Lys GIU Ala Gln Lym Pro 
2113 GCT AAA GAG AAG AAG GCG GCG GCC CCA 
A la  Ly8 GIu Lym Lys Ala Ala Ala Pro 
2209 AAG GCC AAA GAA CCT AGC AAA CCC TCA 
Lys Ala Lys Glu Pro Set Lys Pro Set  
2305 ACT ACG GAG TCC AAG AAG CGT GAG GAG 
Thr  Thr  Glu Set  Lys Lys Arg Glu Glu 
2401"CAG AAA AGG CTG AAA AGT CCT CTA GCA 
Gln Lys Arg Leu Lys Set Prc Leu Ala 
2497 AGG ACG AGA GGG ACA CCC AGA ATA GCC 
Arg Thr  Arg Gly Thr  Pro Arg I le Ala 
2593 TAAGAA GAA ACA CCACTTAGATGG CGG 
2889 CTC CCC AAC ACC AAA GCC CTC CCC AAG 
2785 CGT GAC TAA AAA CTG CCC CCC CTC CTT 
2881 AAA TGC ATT ATG CTT GAA ATG TTG TAA 
2977 GAG CTG CAG CAG GTG AGG CAG GGC GCT 
3073 CCA AGT GCT TCT GA(41) 3086 
GGT CAG ATT CAG GGC TGC GGT 
GIM Gln I le Gln GIy Cys GIy 
CGC GCG CAG CTC GAA GGA CAC 
Arg Ala Gln LeU GIU Gly His 
AAC ACG GAT ~T ATG CGC TCT 
Asn Thr  Asp Ala Met Arg Set 
AAG GAG TCA CTG GAG AGG CAG 
L~'S ~Iu S l r  Leu GIu Ar~ ~n 
CTG AGA AAC ACC AAA TGG GAG 
Leu Arg Amn Thr  Lys Trp Glu 
AGA AAA CTC CTG GAA GGC GAA 
Arq Lys Leu LeU GIu Gly GIU 
CAC ATA AAA GTC AAA AGC GAA 
His I le LyS Val Lys Set Glu 
ACA GAA GAA GTG ACA GAA GAG 
Thr  GIu GIu Val Thr  Glu Glu 
CCT GCA GAA GAG GCT GCA TCT 
Pro Ala GIu GIu Ala A]a SeT 
AAG TCA CCA GCT GAG GCC AAG 
Lys Set  Pro Ala Glu Ala Lys 
CCA GCT GAG GCC AAG TCA CCA 
Pro Ala Glu Ala Lys Set Pro 
GAG GCC AAG TCA CCA GCT GAG 
Glu Ala Lym Set Pro Ala Glu 
AAG TCA CCA GCT GAG GCC AAG 
Lys Set Pro A la  GIU AIa LyS 
CCA GTT ACA GTG AAG TCC CCA 
Pro Val Thr  Val Lys Set Pro 
GGA GCC AAG TCA CCA GCT GAG 
Gly Ala Lys Set Pro Ala Glu 
AAG TCA CCA GCT GAG GCC AAG 
Lys Set  Pro Ala Glu Ala Lys 
CCA GAG AAG GCC AAG AGC CCC 
Pro GIu Lys Ala Lys Set Pro 
AAG CCT CCA GCT GAG GTG ~% 
Lys Pro Fro hla Giu Val Lys 
TCT CCA GAA GCC AAG CCT CCA 
3at  Pro G Iu  A!a Lys Pro Pro 
AAG TCC CCC GAG AAG GAA GA~ 
Lys Set  Pro GIu Lys Glu GIU 
CCA AAG AAG GTG GAG GAG GAG 
Pro Lym Lys Val Glu Glu Glu 
AAG GCG GAG GAG AAG GAG CCT 
Lys Ala  Glu Glu Lys Glu Pro 
GAG GAG GAG ACG CCC GCC AAG 
GIu Glu Glu Thr  Pro Ala Lys 
GAG AAG GAG AAA CCG AAG AAG 
Glu Lys G1u Lys Pro Ly$ Ly$ 
AAA CC~-AAA ATG GAG CCA AGG 
Lys Pro Lys Met  GIU Pro Arg 
CAG ACC AAA AAG ACA GCC AGC 
G!n Thr  Lyz Ly= Thr  Ala Set 
AAA GAA ACT CAG GAC GGC CCC 
Lys GIu Thr  Gln Asp Gly Pro 
GCC CGC CCT CAC CAA ACA GGA 
GTG ATG GAC AAT TAT GAT AGC 
TCC AAG TAA GTG CAT TCA CTT 
CCT ATT CCC GAA TGC CTT CTT 
GGC CGC TGA ACC AGG CCA GGG 
GCC GCG CAG GCG CAG GCT 
Ala Ala Gln Ala Gln Ala 
ACG GTG CAG AGT ACG CTG 
Thr  Val Gin Set Thr  Leu 
GCC CAA GAG GAG ATA ACT 
Ala Gln Glu Gku lle Thr  
CGC TCT GAG CTG GAG GAC 
Arg Set  Clu T~u GI~I Asp 
ATG GCC GCG CAG CTC CGA 
Met Ala Ala Gln Leu Arg 
GAG TGT CGG ATT GGC TTT  
Glu Cys Arg I le Gly Phe 
GAG AAG ATA AAA GTA GTA 
Glu Lys I le Lys Val Val  
GAG GAC AAA GAG GCC CAA 
Glu Asp Lyl GIu Ala Gln 
CCA GAA AAG GAA ACC AAG 
Pro GIu Lys GIu Thr Lys 
TCC CCA GCT GAG GTC AAA 
Ser Pro A la  Glu Val Lys 
GCT GAG GCC AAG TCA CCA 
Ala GlU Ala Lym Set Pro 
GTC AAA TCT CCA GTG GAG 
Val Lys Set  Pro Val Glu 
TCA CCA GCT GAG GTC AAG 
Sat Pro Ala Glu Val Lys 
GCT GA~ GCC AAG TCA CCA 
Ala GIu Ala LyS Set Pro 
GCC AAG TCA CCA GTT GTG 
Ala Lys Set Pro Val Val 
TCT CCA GCT GAG GCC AAG 
Set Pro Ala Glu Ala Lys 
GTG AAG GAA GGT GCA AAA 
Val Lys Glu Gly Ala LZs 
TCC CCC GAG AAG GCC .~AG 
Set PUO Giu Lys A la  Ly~ 
GCG ~AG GAG GAA GCA AAG 
Ala Lys Glu G!U Ala Lys 
ACC AGG ACT GAA ~-%G GTG 
Thr  Arg Thr  GIU Lys Val  
AAG ACA CCA GCC ACA CCA 
Lys Thr  Pru Ala Thr Pro 
CTC ACA GAA AAG CCC AAG 
Leu Thr  Glu Lym Pro Lys 
TTG GGC GTG AAG GAA GAG 
Leu Gly Val  Lys Glu Glu 
GAG GAG GTG CCG GCA GCA 
Glu GIu Val Pro Ala Ala 
CCA AGG AGG AGG ACA AGG 
Pro Arg Arg Arg Thr  Arg 
CCT CAG AGA AGG CCC CAG 
Pro GIll A~g Arg Pro Gln 
GGT ACT CAA GGG TTG GTG 
Gly Thr Gin Gly Leu Val 
TTT CTA TTA GGA TrA AGT 
TTA TCG TAG CCG AAC GGA 
CCC GTA TGT CCT ACC GAC 
GTT TTC CAA AGG AGC GGT 
TGT GCT GTC CAC TGA AGG 
CAG GCC GAG GCT CGG GAC GCC 
Gin Ala GIu A1a Arg Asp Ala 
CAG TCA GAG GAG TGG TTC CGA 
Gln Set  Glu Glu Trp Phe Arg 
GAG TAC CGG CGG CAG CTG CAG 
Glu Tyr  Arg Arg Gln Leu Gln 
CGT CAT CAG GTA GAC ATG GCC 
Arg His Gln Val Asp Met Ala 
GAG TAC CAG GAC CTG CTC AAC 
Glu Tyr  Gln Asp Leu Leu Asn 
GGA CCC ATT CCC TTC TCT CTT 
Gly Pro Ile Pro Pha Set Leu 
GAA AAA TCG GAG AAG GAA ACC 
Glu Lys Set Glu Lym Glu Thr  
GGG GAG GAA GAA GAA GAG GCA 
Gly Glu GIu Glu Glu Glu Ala 
TCT CCT GTG AAA GAA GAG GCC 
Ser Pro Val Lys Gl'a GIu Ala 
TCT CCA GCT GTG GCC AAG TCC 
Set Pro Ala Val A la  Ly$ Set  
GCT GAG GTC AAC TCT CCA GCT 
Ala GIu Val ASh Ser Pro Ala 
GCC AAG TCA CCA GCT GAG GCC 
Ala Lys Set Pro Ala Glu Ala 
TCT CCA GCT ACA GTG AAG TCC 
Ser Pro Ala Thr  Val Lys Set 
GTT GAG GTC AAA TCT CCA GCT 
Val GIU Val Lys Set Pro Ala 
GCC AAA TCA CCA GCT GAG GCC 
Ala Lys Set Pro Ala Glu Ala 
TCT CCA GCT GAG GCC AAG TCA 
Ser Pro Ala GIu Ala Lys Set 
TCC CTA GCT GAG GCC AAG TCC 
Ser Leu Ala Glu Ala Lys Set 
AGC CCC ATG ACC AAG GAG GCC 
SeE Pro Met Arg LyS GIU Ala 
CGC CCC GCA GAC ATC AGA TCC 
Arg Pro Ala Amp lle Arg Set  
GCr CCC AAG AAG GAA GAG GTG 
Ala Pro Lys Lys Glu Glu Val 
AAG ACA GAG GTG AAG GAG AGC 
Lys Thr Glu Val Lys Glu Set 
GAC TCT CO~, GGG GAA GCC AAG 
Asp Set Pro Gly Glu Ala Lys 
GCT AAA CCC .%JKA GAG AAG GCA 
Ala Lys Pro Lys Glu Lys Ala 
CCA GAG AAG AAA GAC ACC AAG 
Pro GIu Lys Lya Asp Thr Lys 
GCC TTC CCC AAG AGC CTA GCA 
Ala Phe Pro Lys Ser LeU Ala 
AGG ACA AGG CTG CCA AGG GAG 
Arg Thr Arg Lau Pro Arg GIu 
T,AA TAA AGT TTA TTT CTT CCT 
TAG CAA GAG A~G ATC AAC CCT 
GAT GTA TTG CTG ~C GCT CCA 
AGG TGA CCG CAG TAA TGA ATG 
CAG GCCCTTGCC CGG TAC ACG 
CCA CTT TCG ATT GCT TCC GTG 
C'I'C AAG TGC 98 
I~u Lys Cys 
GTG AGATTG 192 
Val Arg Leu 
GCC AGG ACC 288 
Ala Arg Thr  
TCC TAC CAG 354 
Set Tyr  Gih 
GTC AAG ATG 480 
Val Lys Met 
ACT GAG GGA 576 
Thr  Glu Gly 
GTC ATT GTA 672 
Val Ile Val 
GAA GAG GGA 768 
GIu Glu Gly 
AAG TCC CCA 884 
Lys =er Pro 
CCA GCT GAA 960 
Pro Ala GIu 
ACA GTG AAG 1056 
Thr  Val Lya 
AAG TCT CCA 1152 
Lym Sat Pro 
CCA GTT GAG 1248 
Pro Val GIu 
TCG GTG AAG 1344 
Set Val Lys 
AAG TCA CCA 1440 
Lys Ser  Pro 
CCA GCT GAG 1536 
Pro Ala GIu 
CCT GAG AAG 1632 
Pro Glu LyS 
~AG TCT CCT 1725 
Lys Set  Pro 
CCT GAG CAG 1824 
Pro GIu Gln 
AAG TCC CCT 1920 
Lys Set Pro 
AAG AAA GAT 2016 
Lys Lys Asp 
AAG GAA GAG 2139 
Lys Glu GIu 
GAA GAC GCC 2206 
GIU Asp Ala 
GAG GAG AAG 3304 
GI~ Glu Lys 
AAC CCA AGA 2400 
Asn Pro Arg 
ACA AGT AAG 2496 
Tnr Ser Lys 
TTC CCT CCG 2592 
GAG CCC TGC 2680 
CGT AAA ACG 2784 
AGC AGT TAG 2880 
CTC CTG GAA 2976 
CAA TAA AAC 3072 
Fig.1. Nucleotide sequence of the 3 kb clone of rat NF-H, and the corresponding deduced amino acid sequence. The untranslated 
region is 529 bases long and includes the poly(A) ÷ tail. 
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3. RESULTS AND DISCUSSION 
The 3 kb clone obtained begins at the end of or- 
helix coil 1B and continues through the carboxy- 
terminal (stop codon) to the poly(A) tail (fig.l). 
The amino acid sequence of coil 2 was found to be 
very highly conserved with respect o both rat NF- 
L and NF-M and also mouse and human NF-H, 
demonstrating a homology of approx. 80°7o and 
90o70, respectively [6,11-13]. This is in good agree- 
ment with previous results which have shown a 
high degree of conservation between the coiled 
regions of intermediate filaments from a number 
of different species [4-6]. There is also a good 
homology between the three species in the last 200 
amino acids or so at the carboxy-terminal of the 
NF-H protein. 
In between these two regions, there is a section 
containing a series of 51 repeated amino acid 
triplets: Lys-Ser-Pro. These occur largely in a se- 
quence of 6 amino acids, in which the Lys-Ser-Pro 
is highly conserved in positions 3-5 of the sextet 
(fig.2). The amino acid in position 2, preceding the 
triplet, is also highly conserved being either Ala or 
Val. There is, however, a greater divergence in the 
first and sixth amino acids of the sextet, but this 
difference is unlikely to influence greatly the 
secondary structure of the region, this probably 
being determined by the triplet repeat sequence. 
The Lys-Ser-Pro sequence has previously been 
identified as the phosphorylation site within NF-H 
[18] and has also been recognized in other 
neurofilament proteins as well as in neurofilament 
and microtubule-associated proteins including 
RAT MOUSE HUMAN L
Glu-Ala-Lys-Ser-Pro-Ala 21 
Glu-Val-Lys-Ser-Pro-Ala 4 
Glu-Ala-Lys-Ser-Pro-Val 3 
Glu-Val-Lys-Ser-Pro-Val 3 
Val-Ala-Lys-Ser-Pro-Ala 2 
Glu-Ala-Lys-Ser-Pro-Ala 2 
Glu~Val-Lys-Ser-Pro-Ser 2 
Glu-Val-Lys-Ser-Pro-Glu 2 
Glu-Ala-Lys-Ser-Pro-Glu 2 
Glu-Thr-Lys-Ser-Pro-Val 1 
Thr-Val-Lys-Ser-Pro-Gly 1 
Ser-Val-Lys-Ser-Pro-Val 1 
Thr-Val-Lys-Ser-Pro-Val 1 
Thr-Val-Lys-Ser-Pro-Ala 1 
Gly-Ala-Lys-Ser-Pro-Ala 1 
Gly-Ala-Lys-Ser-Pro-Glu 1 
Lys-Ala-Lys-Ser-Pro-Met 1 
Asp-Val-Lys-Ser-Pro-Glu 1 
Gln-Val-Lys-Ser-Pro-Ala 1 
Ala-Val-Lys-Ser-Pro-Gly 
Glu-Ala-Lys-Ser-Pro-I le 
Gln-Val-Lys-Ser-Pro-Glu 
Glu-Ala-Lys-Ser-Prp-Gly 
Glu-Ala-Lys-Ser-Pro-Ser 
Glu-Pro-Lys-Ser-Pro-Ala 
Glu-Thr-Lys-Ser-Pro-Pro 
Lys-Ala-Lys-Ser-Pro-Ala 
Glu-Ala-Lys-Ser-Pro-Pro 
Lys-Ala-Lys-Ser-Pro-Val 
Lys-Ala-Lys-Ser-Pro-Thr 
Lys-Ala-Lys-Ser-Pro-Glu 
Lys-Ala-Lys-Ser-Pro-Leu 
Giu-Val-Lys-Ser-Pro-Gly 
Ala-Val-Lys-Ser-Pro-Ala 
15 6 
1 
2 2 
1 1 
- 4 
- i0  
1 
1 
1 
1 
1 
1 
1 
1 
7 
1 
3 
- 1 
- 2 
- 1 
- 8 
- 1 
1 3 
- 1 
3 
1 
TOTAL 51 43 41 
Fig.2. Sequence of the amino acid sextets containing the Lys-Ser-Pro triplet repeat of NF-H of rat, mouse [12] and human [13]. 
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MAP-2 and Tau, indicating that it too, is highly 
conserved [17]. 
A small number of triplet repeats are also pre- 
sent in NF-M [9-11,18], but are absent from NF-L 
[6-8]. Previous studies have shown that the 
number of alkaline phosphatase-sensitive phos- 
phate groups on NF-H and NF-M are approxi- 
mately proportional to the number of triplet 
repeats, these phosphate groups being absent from 
NF-L [19]. This conforms with the proposal that 
the triplet is indeed the site of neurofilament 
phosphorylation. 
There is however, a difference between both the 
total number of triplet repeats present and the in- 
tervening amino acids in the heavy neurofilament 
protein from rat, mouse and human. The mouse 
and human NF-H messages are fairly similar with 
43 and 40 repeat sequences, respectively, whereas 
the rat NF-H has 51 repeats (fig.3). A similar in- 
terspecies difference has also previously been 
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Fig.3. Comparison of the amino acid sequences of the repeat region of rat NF-H, human NF-H [13], and mouse NF-H [12]. Deletions 
(dashes) allow for better alignment of the sequences. 
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noted in the corresponding region of NF-M 
[4,9-11]. 
In the rat NF-H cDNA sequence, 41 of the 
triplet Lys-Ser-Pro repeats occur in a regular pat- 
tern of six amino acids (fig.3). In the mouse, also, 
this regular pattern was seen with 33 of the 43 
triplet repeats present. In the human, however, it 
can be noted that the spacing of the triplets is 
slightly altered with them being separated alter- 
nately by three and five amino acids. There is also 
a considerable difference between the amino acid 
composition of the repeat region between the three 
species. While Ala and Val are conserved in posi- 
tion 2 of the sextet in all three species, there is a 
considerable difference in the amino acid composi- 
tion of positions 1 and 6 (fig.2). The rat NF-H 
favours Glu in position 1 and a nonpolar amino 
acid (Ala or Val) in position 6. In the mouse NF-H, 
however, there is a much greater variation in the 
amino acids present at positions 1 and 6, with no 
clear pattern emerging. In the human NF-H se- 
quence, while there is a broad range of amino acids 
in position 6, two main amino acids, Glu and Lys, 
dominate position 1. As previously mentioned, the 
triplet repeats in the human NF-H are separated 
alternatively by 5 and 3 amino acids. One can 
notice that when one of the extra two amino acids 
present in a 5 amino acid bridge is a lysine residue 
and the subsequent amino acid at position 1 of the 
sextet is usually a Glu residue. Alternatively, when 
there are only three residues between the repeats, 
position 1 is always occupied by a Lys residue. 
From this, one can conclude that the presence of a 
basic amino acid between the triplet repeats may be 
important in human NF-H. The reason for the dif- 
ferences een between species, considering the high 
degree of homology seen in the rest of the proteins, 
is unknown. However, given that the region in 
question is that of phosphorylation, it is possible 
that the interspecies differences between the amino 
acid sequences eparating the triplet repeats may 
reflect different binding requirements for the 
associated protein kinase enzymes, which may ex- 
hibit a high degree of species specificity. 
Neurofilament phosphorylation has been shown 
to be related to the neuronal calibre [19] and is very 
specifically developmentally regulated [2,20]. In 
the perikarya nd developing axons, NF-H is in a 
relatively unphosphorylated form. In mature ax- 
ons, however, NF-H is in a highly phosphorylated 
form, and it is thought hat phosphorylation f the 
polypeptide results in the formation of interfila- 
ment cross bridges that are important in the 
maintenance of axonal calibre [1,4,5]. Therefore 
the triplet repeats in the carboxy region are likely 
to play an important role in the functioning of 
neurofilaments. The acidic carboxy tailpiece of 
neurofilaments has been implicated in the forma- 
tion of interneurofilament cross bridges [4,5] and 
the proximity of the potential phosphorylation site 
to this region would have a major influence on 
protein structure and function. 
In conclusion, therefore, while there are some 
minor differences in the repeat region of the pro- 
tein in the three species examined, these are unlike- 
ly to greatly affect the functioning of this region of 
the protein. Overall, therefore, the amino acid se- 
quence of the NF-H protein is highly conserved 
between the mouse, rat and human species. 
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